公开(公告)号：WO0071493A3

公开(公告)日：2002-01-17

申请号：PCT/US0014138

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： ZHU BING-YAN ,  SU TING ,  ZHAOZHANG JON JIA ,  SCARBOROUGH ROBERT M ,  SONG YONGHONG

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06

CPC classification number: C07C311/40 ,  C07C311/16 ,  C07C311/18 ,  C07C311/44 ,  C07C311/46

Abstract: Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract translation: 公开了与哺乳动物因子Xa具有活性的新型化合物，其盐和与其有关的组合物。 该化合物在体外或体内可用于预防或治疗凝血障碍。

公开(公告)号：CA2374641A1

公开(公告)日：2000-11-30

申请号：CA2374641

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： SCARBOROUGH ROBERT M ,  SONG YONGHONG ,  ZHU BING-YAN ,  SU TING ,  ZHAOZHANG JON JIA

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06

Abstract: Novel compounds, their salts and compositions related thereto having activit y against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

公开(公告)号：AU5155500A

公开(公告)日：2000-12-12

申请号：AU5155500

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： ZHU BING-YAN ,  SU TING ,  ZHAOZHANG JON JIA ,  SCARBOROUGH ROBERT M JR ,  SONG YONGHONG

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06

Abstract: Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.